Positive benefit of postnatal treatment in congenital toxoplasmosis

Translated title of the contribution: Positive benefit of postnatal treatment in congenital toxoplasmosis

Ligia Alejandra Delatorre Cifuentes, Jorge Enrique Gomez-Marin

Research output: Contribution to journalArticlepeer-review

Abstract

A well-established newborn screening programme
for congenital toxoplasmosis has been
reported in a European country with low
prevalence1; however, this programme has also
been implemented in countries with lower
income but with a higher percentage of newborn
infected children. We conducted a study
in 11 public health community hospitals in the
Department of Quindio, excluding the capital
(Armenia), in Columbia; about 4560 children
are delivered in these hospitals annually.
Infants born from August 2003 to December
2003 were enrolled in the study. Informed
consent was obtained from mothers during
sampling and results were reported in accordance
with the resolution 008430 of 1993 of
the Ministry of Public Health concerning
medical research in Colombia. All serum
samples were tested with the Platelia Toxo
IgM Neonatal assay (Bio-Rad, Hercules,
California, USA) as recommended by the
manufacturer. In all, 322 samples were collected,
including 106 dry paper samples from
the heel, which about 25% of which were
insufficient.
Translated title of the contributionPositive benefit of postnatal treatment in congenital toxoplasmosis
Original languageEnglish
Pages (from-to)88-89
Number of pages1
JournalBMJ
Volume92
Issue number1
StatePublished - Dec 22 2006

Fingerprint Dive into the research topics of 'Positive benefit of postnatal treatment in congenital toxoplasmosis'. Together they form a unique fingerprint.

Cite this